P571: ORAL AZACITIDINE VS MIDOSTAURIN AS MAINTENANCE TREATMENT FOR FLT3 MUTANT ACUTE MYELOID LEUKEMIA IN COMPLETE REMISSION: AN INDIRECT TREATMENT COMPARISON
E. N. Oliva,
C. Chen,
S. N. Rahim,
B. Seuro,
A. Vasconcelos,
L. Gaugler,
B. Skikne,
T. Prebet,
H. Cameron,
C. Beach,
G. Thompson
Affiliations
E. N. Oliva
1 Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy
C. Chen
2 Bristol Myers Squibb, Princeton, NJ
S. N. Rahim
2 Bristol Myers Squibb, Princeton, NJ
B. Seuro
3 Eversana, San Diego, CA, United States of America
A. Vasconcelos
2 Bristol Myers Squibb, Princeton, NJ
L. Gaugler
2 Bristol Myers Squibb, Princeton, NJ
B. Skikne
2 Bristol Myers Squibb, Princeton, NJ
T. Prebet
2 Bristol Myers Squibb, Princeton, NJ
H. Cameron
3 Eversana, San Diego, CA, United States of America
